Laprophan Overview
- Year Founded
-
1949
- Status
-
IPO Registration
- Employees
-
1,450
- Latest Deal Type
-
IPO
- (Announced)
- Financing Rounds
-
2
- Investments
-
6
Laprophan General Information
Description
Manufacturer of pharmaceutical products intended to provide innovative and accessible healthcare solutions. The company operates a dedicated research and development center, holds multiple international patents, and manages integrated industrial operations, providing antibiotics, cardiovascular medications, neuropsychiatry treatments, anesthetics, digestive medicines, respiratory treatments, massive solutes, and vitamin supplements, enabling healthcare professionals and patients to access high-quality therapeutic treatments across major medical fields.
Contact Information
Website
www.laprophan.comCorporate Office
- 18 Boulevard Emile Zola
- Casablanca, 20300
- Morocco
Corporate Office
- 18 Boulevard Emile Zola
- Casablanca, 20300
- Morocco
Laprophan Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Laprophan Comparisons
Industry
Financing
Details
Laprophan Competitors (22)
One of Laprophan’s 22 competitors is Glenmark Farmacêutica, a Corporation company based in Sao Paulo, Brazil.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Glenmark Farmacêutica | Corporation | Sao Paulo, Brazil | ||||
| Intas Pharmaceuticals | Private Equity-Backed | Ahmedabad, India | ||||
| Glenmark Pharmaceuticals | Corporation | Mumbai, India | ||||
| Macleods Pharmaceuticals | Corporation | Mumbai, India | ||||
| Celon Labs | Formerly VC-backed | Hyderabad, India |
Laprophan Patents
Laprophan Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-2678042-A1 | Pharmaceutical composition containing phloroglucinol and paracetamol | Active | 19-Feb-2007 | ||
| CA-2678042-C | Pharmaceutical composition containing phloroglucinol and paracetamol | Active | 19-Feb-2007 | ||
| US-20100168238-A1 | Pharmaceutical composition containing phloroglucinol and paracetamol | Active | 19-Feb-2007 | ||
| US-8148425-B2 | Pharmaceutical composition containing phloroglucinol and paracetamol | Active | 19-Feb-2007 | ||
| AU-2002237368-A1 | Use of calcium indomethacin for the treatment of cyclo-oxygenase 2-mediated pathologies | Inactive | 09-Feb-2001 |
Laprophan Signals
Laprophan Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Laprophan Investments (6)
Laprophan’s most recent deal was a Buyout/LBO with Corporate Investment Holding. The deal was made on 20-Oct-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Corporate Investment Holding | 20-Oct-2026 | Buyout/LBO | Holding Companies | ||
| Pian Holding | 05-Feb-2026 | Buyout/LBO | Holding Companies | ||
| Double-e Pharma | 23-Oct-2025 | Buyout/LBO | Consulting Services (B2B) | ||
| Rivopharm | 29-Sep-2025 | Buyout/LBO | Pharmaceuticals | ||
| Botanic Pharma | 25-Jun-2024 | Buyout/LBO | Pharmaceuticals |
Laprophan Affiliates
Subsidiaries (3)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Botanic Pharma | Casablanca, Morocco | 2012 | |
| Amanys Pharma | Ain El Aouda, Morocco | 2011 | |
| Rivopharm | Manno, Switzerland | 1961 |
Laprophan FAQs
-
When was Laprophan founded?
Laprophan was founded in 1949.
-
Where is Laprophan headquartered?
Laprophan is headquartered in Casablanca, Morocco.
-
What is the size of Laprophan?
Laprophan has 1,450 total employees.
-
What industry is Laprophan in?
Laprophan’s primary industry is Pharmaceuticals.
-
Is Laprophan a private or public company?
Laprophan is a Private company.
-
What is Laprophan’s current revenue?
The current revenue for Laprophan is .
-
How much funding has Laprophan raised over time?
Laprophan has raised $72.2M.
-
Who are Laprophan’s investors?
DEG, FMO Entrepreneurial Development Bank, and Mediterrania Capital Partners have invested in Laprophan.
-
Who are Laprophan’s competitors?
Glenmark Farmacêutica, Intas Pharmaceuticals, Glenmark Pharmaceuticals, Macleods Pharmaceuticals, and Celon Labs are some of the 22 competitors of Laprophan.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process